The aggressive nature of aberrant STAT5 activity is illustrated by transgenic mice expressing STAT5BN642H or STAT5AS710F, which develop peripheral T cell lymphoma/leukemia (PTCL), with dominant differentiation toward CD8+ effector memory T cells (16–18). Here, STAT5A is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.